Literature DB >> 27275789

Association of Sexual Debut in Adolescents With Microbiota and Inflammatory Markers.

Vicky Jespers1, Liselotte Hardy, Jozefien Buyze, Jasna Loos, Anne Buvé, Tania Crucitti.   

Abstract

OBJECTIVE: To investigate the association of sexual debut and vaginal, anorectal, and oral microbiota and vaginal inflammatory markers in female adolescents.
METHODS: We conducted a school-based study in adolescents in Antwerp, Belgium. During three visits over 8 months, participants answered questionnaires and self-collected vaginal, anorectal, and oral swabs. Five Lactobacillus species, Lactobacillus genus, Gardnerella vaginalis, and Atopobium vaginae were quantified; and seven inflammatory markers were measured in the vaginal specimens. In the oral and anorectal specimens, Lactobacillus genus, G vaginalis, and A vaginae were ascertained.
RESULTS: Of the 93 adolescents (mean age 16.2 years) at the first visit, 41 (44.1%) had passed sexual debut (penile-vaginal intercourse) and five (5.4%) had sexual experience without passing sexual debut. Having sexual experience at the first visit was not found to be associated with species presence or concentrations (acknowledging an underpowered study because the required sample size was not attained). Modeling the longitudinal data on all girls showed that sexual debut was associated with increased odds of vaginal and anorectal G vaginalis (P=.021; P=.030) and A vaginae (P=.041; P=.012) with increments of interleukins (interleukin [IL]-1α P<.001, IL-1β P=.046, IL-8 P=.033) and chemokines (regulated on activation, normal T cell expressed and secreted P<.001; macrophage inflammatory protein-1β P=.040), whereas no difference was seen when modeling (before-after) the girls initiating and girls staying without sexual intercourse. The association of sexual intercourse with IL-1α (P<.001), IL-1β (P=.030), and IL-8 (P=.002) at the first visit was (greater than 70%) mediated by vaginal G vaginalis and A vaginae concentrations.
CONCLUSION: Sexual debut in adolescents is associated with an inflammatory vaginal reaction and with the presence of bacterial vaginosis-related species. Strategies preventing the colonization of bacterial vaginosis-related organisms during early sexual debut are urgently needed and may prevent acquisition of sexually transmitted infections including human immunodeficiency virus in early life.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27275789     DOI: 10.1097/AOG.0000000000001468

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Immune biomarkers and anti-HIV activity in the reproductive tract of sexually active and sexually inactive adolescent girls.

Authors:  Mimi Ghosh; Mariel Jais; Roshni Biswas; Jason Jarin; Jason Daniels; Christopher Joy; Monika Juzumaite; Vanessa Emmanuel; Veronica Gomez-Lobo
Journal:  Am J Reprod Immunol       Date:  2018-03-13       Impact factor: 3.886

2.  Cytokine response following perturbation of the cervicovaginal milieu during HPV genital infection.

Authors:  Christian Selinger; Massilva Rahmoun; Carmen Lia Murall; Claire Bernat; Vanina Boué; Marine Bonneau; Christelle Graf; Sophie Grasset; Soraya Groc; Jacques Reynes; Christophe Hirtz; Nathalie Jacobs; Samuel Alizon
Journal:  Immunol Res       Date:  2021-04-30       Impact factor: 2.829

3.  Results from a cross-sectional sexual and reproductive health study among school girls in Tanzania: high prevalence of bacterial vaginosis.

Authors:  Suzanna C Francis; Christian Holm Hansen; Julia Irani; Aura Andreasen; Kathy Baisley; Vicky Jespers; Tania Crucitti; John Changalucha; Richard J Hayes; Soori Nnko; Deborah Watson-Jones; Anne Buvé
Journal:  Sex Transm Infect       Date:  2018-12-05       Impact factor: 3.519

4.  Differential sexual network connectivity offers a parsimonious explanation for population-level variations in the prevalence of bacterial vaginosis: a data-driven, model-supported hypothesis.

Authors:  Chris R Kenyon; Wim Delva; Rebecca M Brotman
Journal:  BMC Womens Health       Date:  2019-01-10       Impact factor: 2.809

5.  The Vaginal Microbiome: I. Research Development, Lexicon, Defining "Normal" and the Dynamics Throughout Women's Lives.

Authors:  Hans Verstraelen; Pedro Vieira-Baptista; Francesco De Seta; Gary Ventolini; Risa Lonnee-Hoffmann; Ahinoam Lev-Sagie
Journal:  J Low Genit Tract Dis       Date:  2022-01-01       Impact factor: 1.925

6.  Cervical Squamous Intraepithelial Lesions Are Associated with Differences in the Vaginal Microbiota of Mexican Women.

Authors:  M E Nieves-Ramírez; O Partida-Rodríguez; P Moran; A Serrano-Vázquez; H Pérez-Juárez; M E Pérez-Rodríguez; M C Arrieta; C Ximénez-García; B B Finlay
Journal:  Microbiol Spectr       Date:  2021-10-13

7.  The Vaginal Microbiota Among Adolescent Girls in Tanzania Around the Time of Sexual Debut.

Authors:  Suzanna Carter Francis; Tania Crucitti; Tom Smekens; Christian Holm Hansen; Aura Andreasen; Vicky Jespers; Liselotte Hardy; Julia Irani; John Changalucha; Kathy Baisley; Richard Hayes; Deborah Watson-Jones; Anne Buvé
Journal:  Front Cell Infect Microbiol       Date:  2020-06-25       Impact factor: 5.293

8.  Influence of dapivirine vaginal ring use on cervicovaginal immunity and functional microbiome in adolescent girls.

Authors:  Christina Farr Zuend; Laura Noël-Romas; Sarah Hoger; Stuart McCorriser; Garrett Westmacott; Jeanne Marrazzo; Sharon L Hillier; Charlene Dezzutti; Kathleen Squires; Katherine E Bunge; Adam Burgener
Journal:  AIDS       Date:  2021-03-01       Impact factor: 4.632

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.